Granziera. (2015) The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders. Thrombosis Research 135 , 217-225 /Cohen AT, Imfeld S, Markham J, Granziera S. The use of aspirin for primary and secondary prevention in venous thromboembolism...
(1996). "Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes." Ann. Intern. Med. 124(3): 292-8.Krumholz HM, Radford MJ, Ellerbeck EF et al. Aspirin for secondary prevention after acute myocardial infarction in the elederly: prescribed...
Aspirin represents the sine qua non for antiplatelet pharmacotherapy in patients with cardiovascular diseases because of its well-established role in secondary prevention and its widespread availability and affordability. Historical studies, conducted in an era that bears little resemblance to contemporary cli...
After 30 days, secondary prophylaxis for prevention of recurrent MI should be considered. Use: Usual Adult Dose for Ischemic Stroke Immediate-release: 50 to 325 mg orally once a day Extended-release (ER): 162.5 mg orally once a day
Screening and treatment for hypertension and dyslipidemia and use of aspirin for secondary prevention were consistent with patient eligibility and dosing of national clinical guidelines,17-22 and the probability of risk identification and treatment adherence were consistent with the rates observed within ...
Aspirin can be used for either primary or secondary prevention of cardiovascular disease. Primary prevention refers to use of aspirin in people without known cardiovascular disease to prevent its development. Secondary prevention refers to aspirin use in individuals who have already had a heart attack,...
PPI plus aspirin for secondary cardiovascular disease prevention Aspirin is widely used for cardiovascular disease prevention, but is associated with adverse gastrointestinal effects, which reduce the likelihood of treatment compliance. A new study shows that PPI co-therapy reduces gastrointestinal an... ...
The role of anticoagulation in the secondary prevention of noncardioembolic stroke has long been an area of debate. Previous evidence has shown that anticoagulation is unsafe at an International Normalized Ratio between 3.0 and 4.5. Results of the recently published Warfarin-Aspirin Recurrent Stroke Stu...
New Aspirin Guidelines More The American College of Cardiology recently released new guidelines on aspirin use for the primary prevention of ischemic cardiac events. Specifically, it recommended that for many people, based on the best available evidence, the balance of risks and benefits favors not ...
TRIFLUSAL VERSUS ASPIRIN IN SECONDARY STROKE PREVENTION:RESULTS OF TACIP STUDY 来自 Semantic Scholar 喜欢 0 阅读量: 18 作者:J Matias-Gulu,J Ferro,J Alvarez-Sabin,F Torres 摘要: Study Design. Case report of a young man with rotational burst fracture of the third lumbar vertebra, treated by ...